Ron Laufer

Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana.

Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA.

Remon Medical Technologies, Inc. develops and commercializes assessment and treatment implants. It has developed applications for patient management, post-operative monitoring, nerve and tissue stimulation and local drug delivery. The company was founded by Eyal Doron, Yariv Porat and Yossi Tzaliach in 1997 and is headquartered in Waltham, MA.

MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.

Visium Asset Management LP is an independent hedge fund management firm founded by Jacob Gottlieb in 2005. Headquartered in New York City, the firm provides discretionary investment advisory services and sub-advisory services for various long/short equity, credit, event-driven and multi-strategy private investment funds, registered investment companies, an undertaking for collective investment in transferable securities organized under European Union Directors, and separately managed accounts.

Nanostream, Inc. provides microfluidic analytical systems. The company develops microfluidic systems to automate routine laboratory procedures that are critical to research productivity. It furnishes the miniaturized plumbing critical to the future of pharmaceutical sciences. Nanostream was founded in 1999 and is headquartered in Pasadena, CA.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.